Nektar Therapeutics Stock Forecast - Simple Regression

NKTR Stock  USD 43.34  1.13  2.54%   
The Simple Regression forecasted value of Nektar Therapeutics on the next trading day is expected to be 46.80 with a mean absolute deviation of 3.92 and the sum of the absolute errors of 239.38. Nektar Stock Forecast is based on your current time horizon. Although Nektar Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Nektar Therapeutics' systematic risk associated with finding meaningful patterns of Nektar Therapeutics fundamentals over time.
As of today, the relative strength index (RSI) of Nektar Therapeutics' share price is approaching 43. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Nektar Therapeutics, making its price go up or down.

Momentum 43

 Sell Extended

 
Oversold
 
Overbought
The successful prediction of Nektar Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Nektar Therapeutics and does not consider all of the tangible or intangible factors available from Nektar Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Nektar Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Nektar Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(3.15)
EPS Estimate Current Year
(8.32)
EPS Estimate Next Year
(11.86)
Wall Street Target Price
114.4286
EPS Estimate Current Quarter
(2.79)
Using Nektar Therapeutics hype-based prediction, you can estimate the value of Nektar Therapeutics from the perspective of Nektar Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Nektar Therapeutics using Nektar Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Nektar using crowd psychology based on the activity and movement of Nektar Therapeutics' stock price.

Nektar Therapeutics Short Interest

An investor who is long Nektar Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Nektar Therapeutics and may potentially protect profits, hedge Nektar Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA
32.749
Short Percent
0.0965
Short Ratio
3.16
Shares Short Prior Month
1.8 M
50 Day MA
55.086

Nektar Therapeutics Hype to Price Pattern

Investor biases related to Nektar Therapeutics' public news can be used to forecast risks associated with an investment in Nektar. The trend in average sentiment can be used to explain how an investor holding Nektar can time the market purely based on public headlines and social activities around Nektar Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Nektar Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Nektar Therapeutics.

Nektar Therapeutics Implied Volatility

    
  1.37  
Nektar Therapeutics' implied volatility exposes the market's sentiment of Nektar Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Nektar Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Nektar Therapeutics stock will not fluctuate a lot when Nektar Therapeutics' options are near their expiration.
The Simple Regression forecasted value of Nektar Therapeutics on the next trading day is expected to be 46.80 with a mean absolute deviation of 3.92 and the sum of the absolute errors of 239.38.

Nektar Therapeutics after-hype prediction price

    
  USD 43.19  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Nektar Therapeutics to cross-verify your projections.
To learn how to invest in Nektar Stock, please use our How to Invest in Nektar Therapeutics guide.At this time, Nektar Therapeutics' Inventory Turnover is relatively stable compared to the past year. As of 01/06/2026, Payables Turnover is likely to grow to 4.63, while Asset Turnover is likely to drop 0.18. . As of 01/06/2026, Common Stock Shares Outstanding is likely to grow to about 26.3 M, though Net Loss is likely to grow to (314.8 M).

Open Interest Against 2026-02-20 Nektar Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Nektar Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Nektar Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Nektar Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Nektar Therapeutics' open interest, investors have to compare it to Nektar Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Nektar Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Nektar. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Nektar Therapeutics Additional Predictive Modules

Most predictive techniques to examine Nektar price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nektar using various technical indicators. When you analyze Nektar charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Simple Regression model is a single variable regression model that attempts to put a straight line through Nektar Therapeutics price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

Nektar Therapeutics Simple Regression Price Forecast For the 7th of January

Given 90 days horizon, the Simple Regression forecasted value of Nektar Therapeutics on the next trading day is expected to be 46.80 with a mean absolute deviation of 3.92, mean absolute percentage error of 21.79, and the sum of the absolute errors of 239.38.
Please note that although there have been many attempts to predict Nektar Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Nektar Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Nektar Therapeutics Stock Forecast Pattern

Backtest Nektar TherapeuticsNektar Therapeutics Price PredictionBuy or Sell Advice 

Nektar Therapeutics Forecasted Value

In the context of forecasting Nektar Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Nektar Therapeutics' downside and upside margins for the forecasting period are 41.96 and 51.64, respectively. We have considered Nektar Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
43.34
46.80
Expected Value
51.64
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Nektar Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Nektar Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria121.1918
BiasArithmetic mean of the errors None
MADMean absolute deviation3.9242
MAPEMean absolute percentage error0.0728
SAESum of the absolute errors239.3771
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as Nektar Therapeutics historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for Nektar Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nektar Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nektar Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
38.3543.1948.03
Details
Intrinsic
Valuation
LowRealHigh
39.0160.4765.31
Details
Bollinger
Band Projection (param)
LowMiddleHigh
42.7143.7444.77
Details
8 Analysts
Consensus
LowTargetHigh
104.13114.43127.02
Details

Other Forecasting Options for Nektar Therapeutics

For every potential investor in Nektar, whether a beginner or expert, Nektar Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Nektar Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Nektar. Basic forecasting techniques help filter out the noise by identifying Nektar Therapeutics' price trends.

Nektar Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nektar Therapeutics stock to make a market-neutral strategy. Peer analysis of Nektar Therapeutics could also be used in its relative valuation, which is a method of valuing Nektar Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Nektar Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Nektar Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Nektar Therapeutics' current price.

Nektar Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Nektar Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nektar Therapeutics shares will generate the highest return on investment. By undertsting and applying Nektar Therapeutics stock market strength indicators, traders can identify Nektar Therapeutics entry and exit signals to maximize returns.

Nektar Therapeutics Risk Indicators

The analysis of Nektar Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Nektar Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nektar stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Nektar Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nektar Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nektar Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Nektar Stock

  0.79VTRS ViatrisPairCorr
  0.79TLRY Tilray Inc Earnings Call This WeekPairCorr
  0.73BMY Bristol Myers SquibbPairCorr
  0.72NVS Novartis AG ADRPairCorr
  0.59MRK Merck CompanyPairCorr
The ability to find closely correlated positions to Nektar Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nektar Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nektar Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nektar Therapeutics to buy it.
The correlation of Nektar Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nektar Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nektar Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nektar Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Nektar Stock Analysis

When running Nektar Therapeutics' price analysis, check to measure Nektar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nektar Therapeutics is operating at the current time. Most of Nektar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nektar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nektar Therapeutics' price. Additionally, you may evaluate how the addition of Nektar Therapeutics to your portfolios can decrease your overall portfolio volatility.